Results 91 to 100 of about 6,313 (203)

Exercise management in type 1 diabetes:a consensus statement [PDF]

, 2017
Type 1 diabetes is a challenging condition to manage for various physiological and behavioural reasons. Regular exercise is important, but management of different forms of physical activity is particularly difficult for both the individual with type 1 ...
Admon, Adolfsson, Adolfsson, Adolfsson, Al Khalifah, Arutchelvam, Bally, Bally, Bally, Bartlett, Batacan, Beelen, Bell, Berger, Binek, Blaak, Bohn, Bracken, Bracken, Brazeau, Breton, Burke, Burke, Burke, Camacho, Campbell, Campbell, Campbell, Campbell, Castle, Chimen, Chu, Coker, Colberg, Coyle, Danne, Davey, Davey, Davey, Deane, Dubé, Fahey, Franc, Frankenfield, Frayn, Frid, Frier, Galassetti, Galler, García-García, Garg, Gomez, Graveling, Guelfi, Harmer, Harmer, Heinemann, Heise, Herbst, Hernandez, Hildebrandt, Hirsch, Iscoe, Jabbour, Jeukendrup, Katz, Kelly, Kennedy, Kriska, Lascar, Loucks, Mallad, Maran, Mauvais-Jarvis, Mayor, McAuley, McCarthy, McKnight, Mettler, Miller, Mitranun, Moser, Murphy, Paluska, Perrone, Peter, Phillips, Phillips, Pierre-Louis, Ploug, Quirk, Rabasa-Lhoret, Richardson, Riddell, Riddell, Riddell, Riddell, Robertson, Rönnemaa, Sawka, Shetty, Singhvi, Taleb, Tanenberg, Tansey, Taplin, Teich, Thomas, Tonyushkina, Turner, Turner, van Albada, van Loon, Venables, West, West, Yardley, Yardley, Yardley, Yardley, Yardley, Zaharieva, Zander   +122 more
core   +2 more sources

Hypoglycemia in Type 2 Diabetes Patients Substituted with Insulin Degludec Aspart from Premixed Insulin Therapy: a Quasi Experimental Study

Pakistan Armed Forces Medical Journal
Objective: To determine whether Insulin Degludec Aspart is associated with a reduced risk of hypoglycemia as compared to premixed Insulin aspart therapy in type-2 diabetes mellitus patients. Study Design: Quasi-experimental study Place and Duration
Komal Mumtaz Malik, Sadia Zafar, Shabana Ali, Mudassir Noor, Noaman Ishaq   +4 more
doaj   +1 more source

Pragmatic use of insulin degludec/insulin aspart co-formulation: A multinational consensus statement

Indian Journal of Endocrinology and Metabolism, 2016
Insulin degludec/insulin aspart (IDegAsp) is a modern coformulation of ultra-long-acting basal insulin degludec, with rapid-acting insulin aspart. IDegAsp provides effective, safe, well-tolerated glycemic control, with a low risk of hypoglycemia while ...
Sanjay Kalra, Zafar A Latif, Abdurrahman Comlekci, Guillermo Gonzalez Galvez, Rached Malik, Md Faruque Pathan, Ajay Kumar   +6 more
doaj   +1 more source

Poor glycaemic control is associated with reduced exercise performance and oxygen economy during cardio-pulmonary exercise testing in people with type 1 diabetes [PDF]

, 2017
BackgroundTo explore the impact of glycaemic control (HbA1c) on functional capacity during cardio-pulmonary exercise testing in people with type 1 diabetes.MethodsSixty-four individuals with type 1 diabetes (age: 34 ± 8 years; 13 females, HbA1c: 7.8 ± 1%
A Veves, AS Brazeau, B Stubbe, CA Kindig, D Lucini, E Reske-Nielsen, Eric Zijlstra, F Conconi, GJ Balady, GJ Crowther, H Karakelides, Hanne L. Haahr, I Turinese, JC Baldi, JC Baldi, JP Ribeiro, K Wasserman, Max L. Eckstein, MC Riddell, MP Krause, Olivia McCarthy, Othmar Moser, P Hofmann, P Hofmann, PJ Beckers, R Codella, Rachel Deere, RC Plotnikoff, Richard M. Bracken, S Gusso, S Gusso, S Tagougui, Stephen C. Bain, T Heise, T Yoshida, V Bunc   +35 more
core   +3 more sources

Tirzepatide‐induced body composition changes: Implications from the SURPASS‐3 MRI substudy

Journal of Diabetes Investigation, EarlyView.
I‐Weng Yen, Hung‐Yuan Li
wiley   +1 more source

Concentrated insulins: the new basal insulins

Therapeutics and Clinical Risk Management, 2016
Elizabeth M Lamos,1 Lisa M Younk,2 Stephen N Davis3 1Division of Endocrinology, Diabetes and Nutrition, 2Department of Medicine, University of Maryland School of Medicine, 3Department of Medicine, University of Maryland Medical Center, Baltimore, MD ...
Lamos EM, Younk LM, Davis SN
doaj  

Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain [PDF]

, 2015
Introduction: An Excel® (Microsoft Corporation) model was adapted to estimate the short-term (1-year) cost effectiveness of insulin detemir (IDet) versus neutral protamine Hagedorn (NPH) insulin in patients initiating insulin treatment with type 1 ...
A Philis-Tsimikas, AE Pontiroli, AJ Lee, AJ Palmer, American Diabet es Association, BM Frier, D Orozco-Beltrán, ER Seaquist, F Alvarez Guisasola, J Smith-Palmer, JA Sacristán, K Eeg-Olofsson, K Hermansen, LF Meneghini, M Brod, M Evans, M Hammer, M Monami, M Ridderstråle, MH Gschwend, PC Bartley, PE Cryer, PE Cryer, SA Williams, SE Inzucchi, UK Hypoglycaemia Study Group, WJ Valentine, WJ Valentine, WJ Valentine   +28 more
core   +2 more sources

Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA [PDF]

, 2018
Introduction: Basal insulin (BI) plays an important role in treating type 2 diabetes (T2D), especially when oral antidiabetic (OAD) medications are insufficient for glycemic control.
A Stokes, AJ Garber, American Diabetes Association, D Mauricio, EM Heintjes, IM Stratton, J Gordon, K Esposito, K Hermansen, K Khunti, K Khunti, L Berard, M Peyrot, N Wu, O Steen, P Dandona, PA Levin, S Vijan, SB Harris, SD Lin, SE Inzucchi, SG Kim, SI McFarlane, V Valentine, WD Strain, WH Polonsky, X Cai   +26 more
core   +2 more sources

Effects of Switching from Degludec to Glargine U300 in Patients with Insulin-Dependent Type 1 Diabetes: A Retrospective Study

Medicina
Background and Objectives: Degludec (Deg) and glargine U300 (Gla-300) are insulin analogs with longer and smoother pharmacodynamic action than glargine U100 (Gla-100), a long-acting insulin that has been widely used for many years in type 1 and type 2 ...
Toshitaka Sawamura, Shigehiro Karashima, Azusa Ohbatake, Takuya Higashitani, Ai Ohmori, Kei Sawada, Rika Yamamoto, Mitsuhiro Kometani, Yuko Katsuda, Takashi Yoneda   +9 more
doaj   +1 more source

Basal insulin analogues in the treatment of diabetes mellitus: What progress have we made?

Indian Journal of Endocrinology and Metabolism, 2015
Over the past few decades, continuous progress has been made in the development of insulin therapy. Basal insulins were developed around 60 years ago. However, existing basal insulins were found to have limitations. An ideal basal insulin should have the
Sanjay Kalra
doaj   +1 more source